Skip to Content

Tribenzor Dosage

Generic name: OLMESARTAN MEDOXOMIL 20mg, AMLODIPINE BESYLATE 5mg, HYDROCHLOROTHIAZIDE 12.5mg
Dosage form: tablet, film coated

Medically reviewed on July 1, 2017.

Dose once daily. Dosage may be increased in 2 week intervals, as needed. The maximum recommended dose of Tribenzor is 40/10/25 mg.

Dose selection should be individualized based on previous therapy.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Tribenzor (amlodipine / hydrochlorothiazide / olmesartan)

Consumer resources

Professional resources

Tribenzor (FDA)

Related treatment guides

High Blood Pressure

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

WADA Class Anti-Doping Classification

Manufacturer

Daiichi Sankyo

Drug Class

Miscellaneous antihypertensive combinations

Related Drugs

High Blood Pressure amlodipine, lisinopril, losartan, furosemide, hydrochlorothiazide, metoprolol, atenolol, Lasix, Norvasc, valsartan, enalapril, Diovan, irbesartan, Cozaar, Lopressor, Toprol-XL, Bystolic, Benicar, olmesartan, Avapro, hydrochlorothiazide / lisinopril, hydrochlorothiazide / triamterene, Dyazide, More...

Tribenzor Rating

19 User Reviews 7.7/10

Tribenzor Images

Pill Imprint C51 (Tribenzor 5 mg / 12.5 mg / 20 mg)

Tribenzor 5 mg / 12.5 mg / 20 mg (C51)

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 9 Jan 2019), Cerner Multum™ (updated 14 Jan 2019), Wolters Kluwer™ (updated 7 Jan 2019) and others. Refer to our editorial policy for content sources and attributions.